AnmeldungE-Mail RegistrierungKontakt

ENDOCOR wins EuroPCR 2013 Ethica Award

21 May 2013, Paris, France: EuroPCR, the annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) and the world-leading course in interventional medicine, today gave its annual award to the entire cardiovascular device industry for their pioneering and outstanding contribution to innovative patient care.

Presenting the award, William Wijns, Chairman of PCR and Course Director of EuroPCR, said, “Over the past 30 years, the cardiovascular device industry has developed a range of innovative devices and technologies that have enabled interventional cardiologists to transform medicine.” Interventional cardiologists use narrow tubes, or catheters, passed through arteries or veins to reach the heart or other organs to carry out operations from the inside by inserting devices that treat disease.

Fellow Course Director of EuroPCR Jean Fajadet said, “Devices such as drug-eluting stents and mechanical valves enable us to treat patients less invasively, to treat patients for whom they were previously no treatment options and, more recently, to perform interventional procedures that improve survival as well as quality of life.”

The development of medical devices has enabled clinicians to take procedures that once were open surgical procedures that would take several hours and make them less invasive, catheter-based procedures that reduce risk, morbidity and mortality for patients.
Examples include: balloon angioplasty, which opens arteries by inflating a balloon to maintain blood flow without having to perform open surgery; stents (tiny mesh tubes) that hold arteries open to prevent ischaemic events including heart attacks; drug-eluting stents, which gradually release medicine to prevent a blood vessel narrowing again; mechanical valves, which replace damaged valves in the heart, restoring the control of blood flow that is lost in people with heart valve disease; and technologies that minimise the risk of a stroke.

Each year the EuroPCR Board gives the Ethica Award to remarkable individuals who have significantly contributed to the field of cardiovascular intervention either as teachers, scientists, care providers or pioneers, or – as often the case – all of these at once.